Suppr超能文献

自闭症谱系障碍的解剖学与细胞生物学:来自人类遗传学的经验教训

Anatomy and Cell Biology of Autism Spectrum Disorder: Lessons from Human Genetics.

作者信息

Kleijer Kristel T E, Huguet Guillaume, Tastet Julie, Bourgeron Thomas, Burbach J P H

机构信息

Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France.

出版信息

Adv Anat Embryol Cell Biol. 2017;224:1-25. doi: 10.1007/978-3-319-52498-6_1.

Abstract

Until recently autism spectrum disorder (ASD) was regarded as a neurodevelopmental condition with unknown causes and pathogenesis. In the footsteps of the revolution of genome technologies and genetics, and with its high degree of heritability, ASD became the first neuropsychiatric disorder for which clues towards molecular and cellular pathogenesis were uncovered by genetic identification of susceptibility genes. Currently several hundreds of risk genes have been assigned, with a recurrence below 1% in the ASD population. The multitude and diversity of known ASD genes has extended the clinical notion that ASD comprises very heterogeneous conditions ranging from severe intellectual disabilities to mild high-functioning forms. The results of genetics have allowed to pinpoint a limited number of cellular and molecular processes likely involved in ASD including protein synthesis, signal transduction, transcription/chromatin remodelling and synaptic function all playing an essential role in the regulation of synaptic homeostasis during brain development. In this context, we highlight the role of protein synthesis as a key process in ASD pathogenesis as it might be central in synaptic deregulation and a potential target for intervention. These current insights should lead to a rational design of interventions in molecular and cellular pathways of ASD pathogenesis that may be applied to affected individuals in the future.

摘要

直到最近,自闭症谱系障碍(ASD)仍被视为一种病因和发病机制不明的神经发育疾病。随着基因组技术和遗传学的革命,以及其高度的遗传性,ASD成为第一种通过易感基因的遗传鉴定揭示分子和细胞发病机制线索的神经精神疾病。目前已确定了数百个风险基因,在ASD人群中的复发率低于1%。已知的ASD基因的多样性和复杂性扩展了临床观念,即ASD包括从严重智力残疾到轻度高功能形式等非常异质的病症。遗传学研究结果已能够确定有限数量的可能与ASD相关的细胞和分子过程,包括蛋白质合成、信号转导、转录/染色质重塑和突触功能,这些过程在大脑发育过程中对突触稳态的调节都起着至关重要的作用。在此背景下,我们强调蛋白质合成在ASD发病机制中作为关键过程的作用,因为它可能是突触失调的核心,也是潜在的干预靶点。这些当前的见解应能促使人们合理设计针对ASD发病机制分子和细胞途径的干预措施,未来可能应用于受影响的个体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验